SOURCE: Parenteral Drug Association (PDA)

October 23, 2007 13:24 ET

Cancer Research Supporters Linda Armstrong Kelly and Shelley Morrison to Deliver Keynote Presentations at PDA 2008 Annual Meeting

BETHESDA, MD--(Marketwire - October 23, 2007) - The Parenteral Drug Association (PDA) has confirmed that Linda Armstrong Kelly and Shelley Morrison will speak during the Opening Plenary Session at the PDA 2008 Annual Meeting in Colorado Springs, Colorado, April 14-18, 2008. Kelly and Morrison will kick off the PDA 2008 Annual Meeting with keynote presentations that explore their stories of survival and tireless efforts to make the public, government and industry aware of the need to support further development and distribution of innovative and efficacious drugs to treat cancer. Their presentations will set the stage for other patient point-of-view stories and how organizations may have contributed to their well-being and/or recovery.

Linda Armstrong Kelly is the mother of seven-time Tour de France Champion Lance Armstrong, who credits her as the unsung hero who assisted him in reaching his cycling victories and his triumph over cancer. Her life experiences as a teenage mother living in poverty and raising an unstoppable baby boy helped form the values and positive attitude that both she and Lance carried forward into adulthood. Her recent television appearances include "The Dr. Phil Show," CNN, ESPN and the "Oprah" show. In 2005, she published "No Mountain High Enough - Raising Lance, Raising Me."

Shelley Morrison is a veteran of the big and small screens with more than 40 years in show business. She has worked in film and television since the 1960s. Her role as Rosario on "Will and Grace" has earned her Emmy and SAG Awards and numerous nominations, including three ALMA Nominations for Best Supporting Actress. Morrison recently led the "Sea of Pink" ceremony to kick off the Susan G. Komen Race for the Cure in Los Angeles. She has survived two bouts with cancer and retains a spirit of peace and optimism.

These Opening Plenary Session presentations will set the stage for two-and-a-half days of conference sessions focused on Science Driven Manufacturing: The Application of Emerging Technologies and covering:

--  The patient point-of-view and how an organization may have contributed
    to their well-being and/or recovery
--  Novel manufacturing technologies that enhance patient safety
--  New contaminants implications, detection and exclusion
    

Immediately following the conference, the PDA Training and Research Institute (PDA TRI) is offering training courses to complement conference sessions.

The PDA 2008 Annual Meeting will be held in Colorado Springs, Colorado, April 14-18, 2008, at The BROADMOOR resort.

For more information, visit www.pda.org/annual2008.

About PDA

Connecting People, Science and Regulation®

The Parenteral Drug Association (PDA) is a nonprofit international organization and a leading global provider of science, technology, and regulatory information and education for the pharmaceutical and biopharmaceutical community. PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 10,000 members worldwide. More information about PDA is available at www.pda.org.

Contact Information

  • Contact:
    Dee Kaminsky
    Email Contact
    Tel: +1 (301) 656-5900, ext. 145

    PDA Global Headquarters
    Bethesda Towers
    4350 East West Highway, Suite 200
    Bethesda, MD 20814
    Tel: +1 (301) 656-5900
    Fax: +1 (301) 986-0296